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ABSTRACT
Background: There are limited data to determine the impact of subarachnoid
blockade with local anesthetics on perioperative pulmonary function. The effects of
local anesthetics used in spinal anesthesia are very important in terms of respiratory
function in patients with chronic obstructive pulmonary disease (COPD).
Objective: The aim of this study was to evaluate the effects of bupivacaine
versus levobupivacaine on pulmonary function in patients with COPD undergoing
urologic surgery.
Methods: Patients were randomized into 2 groups: group B (n  25) received
mL of hyperbaric 0.5% bupivacaine; group L (n  25) received 3 mL of isobaric
.5% levobupivacaine. Both agents were administered intrathecally. Forced vital
apacity (FVC), forced expiratory volume in 1 second (FEV1), peak expiratory flow
ate (PEFR), vital capacity (VC), and FEV1/FVC ratio were measured using spirom-
etry 10 and 30 minutes after spinal anesthesia and 30 minutes after completion of the
operation. An arterial blood gas test was performed before and after spinal anesthesia.
Results: Fifty male patients aged 40 to 80 years completed the study. There
were no differences in the results of preoperative and postoperative FVC, FEV1,
PEFR, VC, FEV1/FVC ratio, and arterial blood gas between the bupivacaine (n 25)
nd levobupivacaine (n  25) groups. However, patients who took bupivacaine
howed a significant decrease in intraoperative PEFR at 30 minutes compared with
aseline, a result not seen in patients who took levobupivacaine (P  0.036 and P 
.282, respectively).
Conclusions: In 50 patients with moderate COPD undergoing urologic
urgery, hyperbaric bupivacaine caused a decrease in intraoperative PEFR compared
ith baseline because of higher level block; however, the effects of hyperbaric
upivacaine and isobaric levobupivacaine on pulmonary function in these patients
Accepted for publication June 28, 2011. doi:10.1016/j.curtheres.2011.06.003
© 2011 Elsevier HS Journals, Inc. 0011-393X/$ - see front matter
164
Open access under the Elsevier OA license.
©b
a
S.H. Sahin et al.showed equally effective potencies for spinal anesthesia. (Curr Ther Res Clin Exp. 2011;
72:164-172)
2011 Elsevier HS Journals, Inc.
Key words: bupivacaine, chronic obstructive pulmonary disease, levobupiva-
caine, respiratory function tests.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is the most common pulmonary
disorder encountered in anesthetic practice.1,2 Most patients are only slightly symp-
tomatic or are asymptomatic. Although regional anesthesia is often preferred to
general anesthesia, high spinal or epidural anesthesia may reduce lung volumes,
restrain the use of accessory respiratory muscles, and produce an ineffective cough,
which leads to dyspnea with retention of secretions.1,2
Previous studies have demonstrated the effects of levobupivacaine and racemic
upivacaine on patients undergoing urologic surgery.3,4 However, the effects of
intrathecal bupivacaine and levobupivacaine on respiratory function of patients with
COPD undergoing elective transurethral surgery have not been studied. Levobupi-
vacaine, the S-(–)-isomer of bupivacaine, is a long-acting local anesthetic that shows
less toxicity in the cardiac and central nervous systems compared with bupivacaine.5,6
In this study, our aim was to evaluate the effect of spinal anesthesia with 0.5%
hyperbaric bupivacaine versus 0.5% isobaric levobupivacaine on the pulmonary
function of patients with COPD undergoing elective transurethral surgery.
PATIENTS AND METHODS
This single-center, prospective, randomized, double-blind study was conducted at the
Trakya University Medical Faculty. After obtaining approval from the local ethics
committee and written informed consent, 53 male patients aged 40 to 80 years with
moderate COPD and American Society of Anesthesiologists (ASA) II–III physical
status who were scheduled for elective transurethral surgery under spinal anesthesia
were enrolled in the study.
Patients were classified according to Global Initiative for Chronic Obstructive
Lung Disease (GOLD) guidelines.7 All patients were in GOLD stage II with moderate
irflow obstruction, defined as forced expiratory volume in 1 second (FEV1) of 50%
to 80%, and were current or ex-smokers with a smoking history of 10 packs/year
(FEV1/forced vital capacity [FVC] ratio 70%).
Exclusion criteria were coagulation disturbances, neuromuscular diseases, morbid
obesity, hypersensitivity to amide local anesthetics, infection at the injection site,
bronchial asthma requiring regular therapy, cardiac problems associated with dys-
pnea, and severe psychiatric disorders.
No patients received premedication. On arrival in the anesthetic room, a 16-gauge
intravenous cannula was inserted and 500-mL lactated Ringer solution was infused
for 20 minutes. Monitored parameters were 3-lead electrocardiogram, heart rate
Open access under the Elsevier OA license.(beats/min), noninvasive blood pressure (mm Hg), and pulse oximetry (SpO2 [%]).
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Current Therapeutic ResearchThe random assignments of patients were prepared outside the study center and
nserted in opaque, sealed, sequentially numbered envelopes. Patients in group B
n  25) received 3 mL of hyperbaric 0.5% bupivacaine*; patients in group L (n 
5) received 3 mL of isobaric levobupivacaine.† Hyperbaric 0.5% bupivacaine or
sobaric levobupivacaine was administered in a randomized, double-blind fashion
fter local infiltration with 2 mL of lidocaine 2%. Both drugs were aseptically and
ntrathecally administered to patients in a sitting position, through a 25-gauge
uincke point spinal needle by a midline approach between the L3–L4 intervertebral
pace. After the free flow of cerebrospinal fluid was verified, local anesthetic was given
ver 15 seconds, without aspiration. The anesthesiologist performing the spinal
nesthesia was not aware of group allocation. A separate independent anesthesiologist
repared all local anesthetic solutions. Immediately after administration, the patients
ere turned to a supine position. During the procedure, supplementary oxygen at 2
/min was given via face mask.
Sensory and motor blocks were assessed by the pinprick test (1  hypoalgesia;
 analgesia; 3  analgesia plus hypoesthesia; 4 anesthesia) and by a modified
romage scale (0 no motor block; 1 ability to move knees only, inability to raise
xtended legs; 2  inability to flex knees; 3  fully motor block), respectively. The
nesthetist performing the pinprick test and modified Bromage scale was blinded to
roup allocation. Sensory and motor onset time, maximal spread of sensory block,
uration of sensory and motor block, and time to L2 segment regression (time to
umbar spine 2 segment regression of spinal anesthesia) were recorded.
When the sensory block reached the T10 level (Thoracic dermatome), patients were
laced in the lithotomy position for surgery and the surgical procedure was started.
ntraoperatively, the patients received 10 mL/kg/h of lactated Ringer solution.
Anesthetic and vital parameters were recorded every 2 minutes for the first 30
inutes after the intrathecal injection, every 5 minutes during the surgical procedure,
nd every hour postoperatively until motility and sensitivity returned to basal
onditions.
Mean arterial pressure 60 mm Hg, or a decrease 25% from baseline, was
efined as hypotension and treated with a 5-mg ephedrine bolus; a heart rate 50
eats/min was defined as bradycardia and treated with 0.5 mg of atropine. A decrease
n SpO2 to 93% was defined as hypoxia and treated with supplemental assisted
entilation by a face mask.
For spirometric measurements, the Spiro Analyzer ST-90 (Fukuda Sangyo, Tokyo,
apan) was used. Spirometry was standardized with each patient in the supine position
n the bed or operating table with a 30-degree head-up position. The anesthetist
erforming spirometry monitoring and evaluating was blinded to group allocation.
fter an exact demonstration of the correct usage during the pre-anesthetic visit, we
erformed spirometry and the measurement was determined as the baseline. The
VC, FEV1, peak expiratory flow rate (PEFR), vital capacity (VC), and FEV1/FVC
*Trademark: Marcaine® Heavy 0.5% (AstraZeneca, Södertälje, Sweden).
†Trademark: Chirocaine® (Abbott Scandinavia AB, Solna, Sweden).
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S.H. Sahin et al.ratio were calculated using spirometry at the operating room 10 and 30 minutes after
spinal anesthesia and 30 minutes after the completion of the operation. At assessment,
spirometry was performed at least 3 times to meet the criteria of the European
Respiratory Society, and the best measurement was recorded.8
Arterial blood was usually obtained by percutaneous needle puncture of a palpable
rtery. Primarily radial arteries were used. We measured arterial blood gas on arrival
t the operating room and 30 minutes after the end of the operation (during 30
inutes under supplemental oxygen) (ABL 800 Series; Radiometer America, West-
ake, Ohio).
Statistical Analysis
An unpaired t test was applied to compare the data between groups; a paired t test
was applied to compare data within the groups. Normal distribution of data was
tested via 1 sample Kolmogorov-Smirnov test. P  0.05 was considered to be
significant. For calculations, the Statistica 7.1 software program was used (StatSoft,
Tulsa, Oklahoma).
RESULTS
Of 53 patients assessed for eligibility, 3 patients were excluded because of failed
spinal anesthesia. Fifty patients were followed according to protocol. Twenty-five
patients were included in each of the 2 groups (Figure). The 2 groups have homo-
geneous results relating to age, weight, height, body mass index, ASA physical status,
and duration of surgery (Table I).
There were no differences in mean arterial pressure, heart rate, and SpO2 between
he groups. In all patients, SpO2 values remained higher than 97% during the
rocedure. No patients required sedation.
There were no significant differences between groups regarding sensory and motor
nset times, maximal spread of sensory block, duration of sensory block and motor
lock, and time to L2 segment regression of spinal anesthesia (Table II; P  0.081,
 0.071, P  0.301, P  0.068, P  0.349, and P  0.069, respectively). The
block level at 15 minutes after the subarachnoid injection was significantly higher in
patients who received bupivacaine than in patients who received levobupivacaine
(P 0.011). No adverse effects, such as hypotension, bradycardia, nausea, respiratory
depression, or weakness, were observed.
FVC, FEV1, VC, and FEV1/FVC ratio did not differ significantly from baseline to
0 minutes, 30 minutes, and the postoperative period in either group. Patients in the
upivacaine group showed a significant decrease in intraoperative PEFR at 30
inutes compared with baseline, which was a result not seen in the levobupivacaine
roup (Table III; P 0.036 and P 0.282, respectively). The values of FVC, FEV1,
PEFR, VC, and FEV1/FVC ratio showed no significant differences between the groups
in the intraoperative (10 and 30 minutes) and postoperative periods (Table III).
There were no differences in intraoperative and postoperative arterial blood gas
results for the values of potential hydrogen, partial pressure of oxygen, partial pressure
of carbon dioxide, bicarbonate, base excess, and SpO2 between the two groups.
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wCurrent Therapeutic ResearchPostoperative arterial blood gas results of potential hydrogen, partial pressure of
oxygen, partial pressure of carbon dioxide, bicarbonate, base excess, and SpO2 did not
differ from the intraoperative values in either group.
DISCUSSION
In this study the intrathecal administration of 0.5% hyperbaric bupivacaine or 0.5%
isobaric levobupivacaine to 2 separate but homogeneous groups of patients with
COPD undergoing elective transurethral surgery showed no significant differences
with regard to pulmonary function. However, hyperbaric bupivacaine decreased
intraoperative PEFR at 30 minutes from baseline.
Patients with severe chronic lung insufficiency may depend on intercostal and abdom-
inal muscles to actively inspire or exhale. Furthermore, clearing of secretions and effective
coughing require intercostal and abdominal muscles for expirations.2 These muscles
Figure. Disposition of patients randomly assigned to receive hyperbaric bupivacaine (n 
25) or isobaric levobupivacaine (n  25) in this study to evaluate the effects of
these agents on pulmonary function in patients with chronic obstructive pulmo-
nary disease undergoing urologic surgery.ould be damaged by the high levels of neuraxial block with local anesthetics. Thus,
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COPD. A regional technique may not be the best choice in patients with severe lung
disease for surgical procedures above the umbilicus.9,10 Therefore, we performed spinal
anesthesia for transurethral surgery using bupivacaine or levobupivacaine.
PEFR is a good indicator of cough effectiveness. The abdominal muscles are
important in producing an effective cough because they increase intra-abdominal
pressure and intrapulmonary pressure.11,12 Therefore, we believe that the subarach-
noid blockade with local anesthetic used in our study decreased PEFR by inducing
motor blockade of the abdominal wall muscles. Because the hyperbaric bupivacaine
provided a higher level block compared with isobaric levobupivacaine, patients who
received bupivacaine showed a significant decrease in intraoperative PEFR at 30
minutes compared with baseline. However, there were no significant differences
between the groups regarding PEFR. The present study indicated that from the
standpoint of respiration, hyperbaric bupivacaine and isobaric levobupivacaine in
spinal anesthesia are both well tolerated by patients with COPD.
Table I. Demographic data. Data are given as mean (SD) unless otherwise specified.
Characteristic Bupivacaine (n  25) Levobupivacaine (n  25) P*
ge, y 65.50 (10.23) 67.55 (7.11) 0.466
eight, kg 69.40 (10.15) 74.45 (10.21) 0.125
eight, cm 169.20 (4.59) 167.60 (5.68) 0.334
ody mass index, kg/m2 22.05 (0.99) 22.08 (0.91) 1.000
ASA physical status, II/III 14/6 13/7 0.685
Duration of surgery, min 65.50 (17.23) 62.25 (12.59) 0.066
ASA  American Society of Anesthesiologists.
*No statistically significant differences were obtained in any of the parameters among groups (P 
0.05).
Table II. Spinal anesthesia characteristics. Data are given as mean (SD) unless otherwise
specified.
Characteristic
Bupivacaine
(n  25)
Levobupivacaine
(n  25) P
Sensory onset time, min 7.85 (1.13) 9.80 (0.89) 0.081
Motor onset time, min 8.65 (1.38) 9.75 (1.20) 0.071
Maximal spread of sensory block* T7 (4–10) T8 (4–10) 0.301
Duration of sensory block, min 259.65 (22.79) 245.15 (19.85) 0.068
Duration of motor block, min 238.70 (20.66) 246.50 (30.45) 0.349
Time to L2 segment regression, min 223.60 (68.66) 231.50 (70.45) 0.069
L2  lumbar spine 2 segment; T7  thoracic dermatome 7.
*Values are median (range).
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Table III. Preoperative, intraoperative, and postoperative pulmonary function test results. Data are given as mean (SD).
Test Time
Bupivacaine
(group B; n  25)
Levobupivacaine
(group L; n  25)
P (group B
vs group L)
P ( preoperative;
group B vs group L)
FVC, L Preoperative 2.91 (0.13) 2.92 (0.17) 0.080
10 min 3.01 (0.14) 3.01 (0.17) 0.907 0.087
30 min 2.89 (0.17) 2.92 (0.15) 0.279 0.074
Postoperative 3.02 (0.16) 2.93 (0.19) 0.222 0.088
FEV1, L Preoperative 2.01 (0.09) 2.02 (0.10) 0.975
10 min 2.04 (0.07) 2.05 (0.03) 0.625 0.063
30 min 2.02 (0.05) 2.03 (0.12) 0.718 0.072
Postoperative 2.06 (0.10) 2.05 (0.04) 0.594 0.196
PEFR, L/min Preoperative 303.70 (16.89) 299.50 (17.31) 0.442
10 min 294.40 (19.01) 292.90 (22.23) 0.820 0.078
30 min 265.50 (19.02) 293.80 (15.91) 0.282 0.036*
Postoperative 287.75 (13.74) 293.95 (25.08) 0.320 0.371
VC, L Preoperative 2.20 (0.09) 2.16 (0.09) 0.192
10 min 2.18 (0.09) 2.20 (0.11) 0.557 0.089
30 min 2.23 (0.12) 2.18 (0.10) 0.181 0.162
Postoperative 2.17 (0.13) 2.15 (0.10) 0.314 0.362
FEV1 /FVC, % Preoperative 68.27 (2.18) 68.37 (2.03) 0.375
10 min 67.67 (2.41) 67.20 (2.44) 0.846 0.279
30 min 68.79 (2.24) 68.52 (2.28) 0.489 0.282
Postoperative 68.23 (2.24) 68.40 (2.28) 0.469 0.279
FEV1  forced expiratory volume in 1 second; FVC  forced vital capacity; PEFR  peak expiratory flow rate; VC  vital capacity.
*Differences were significant in group B at 30 minutes for PEFR.
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S.H. Sahin et al.A subarachnoid blockade with local anesthetics causes a decrease in diaphragmatic
train due to the block of the motor nerve fibers to the abdominal wall muscles.
herefore, the diaphragm moves more easily during inspiration. This mechanism
ould make the inspiratory lung volume increase and prevent spirometric parameters
rom decreasing.11 Therefore, subarachnoid blockade with hyperbaric bupivacaine or
isobaric levobupivacaine induced almost no changes in FVC, FEV1, VC, and FEV1/
FVC ratio in our study.
Levobupivacaine recently has been introduced into clinical practice because of its
lower toxic effects on the heart and central nervous system.5 Therefore, levobupiva-
aine may be a good alternative for spinal anesthesia during transurethral surgery in
ritically ill patients. However, previous studies did not include data regarding the
pread, sensory block, and motor block of spinal anesthesia with isobaric and hyper-
aric local anesthetic solutions and the effect of pulmonary function in patients with
OPD. The addition of dextrose to local anesthetics increases the density and obtains
high sensory block.13 The gravity of the injection into the subarachnoid space is
nown to influence the spread of subarachnoid blockade.14 Based on information from
he producers, the gravity of hyperbaric bupivacaine and isobaric levobupivacaine
ere 1.028 and 1.004, respectively. The hyperbaric bupivacaine (addition of dextrose)
rovided a higher level block, compared with the isobaric levobupivacaine, without
eading to deterioration in respiratory function and arterial blood gas tests in our
tudy.
Our study was limited by several factors, particularly sample size. An increase in
he sample size may change the results. Similarly, if the sample size were larger,
ignificant differences in the results might be determined, so the conclusions might
e stricter. Another limitation is that the use of other local anesthetic drugs may
ffect the study results.
CONCLUSIONS
Hyperbaric bupivacaine can cause a decrease in intraoperative PEFR compared with
baseline because of higher level block. The effects of hyperbaric bupivacaine and
isobaric levobupivacaine on pulmonary function in patients with COPD, however,
show equally effective potencies for spinal anesthesia. This hypothesis awaits further
studies to establish its clinical significance.
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